Patents for C07K 19 - Hybrid peptides (29,428) |
---|
11/22/2001 | WO2001088138A1 Humanised antibodies to the epidermal growth factor receptor |
11/22/2001 | WO2001088085A2 Novel bee venom polypeptides and methods of use thereof |
11/22/2001 | WO2001087982A2 Immunotoxin fusion proteins and means for expression thereof |
11/22/2001 | WO2001087981A2 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof |
11/22/2001 | WO2001038355A3 Method of forming a peptide-receptor complex with zsig33 and therapeutic use thereof |
11/22/2001 | WO2001036639A3 Bt toxin receptors from lepidopteran insects and methods of use |
11/22/2001 | WO2001030371A3 Novel chimeric analgesic peptides |
11/22/2001 | WO2001027268A3 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
11/22/2001 | WO2001027146A3 Chemokine receptor |
11/22/2001 | US20010044523 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
11/22/2001 | US20010044144 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
11/22/2001 | CA2409746A1 Immunotoxin fusion proteins and means for expression thereof |
11/22/2001 | CA2409361A1 Humanised antibodies to the epidermal growth factor receptor |
11/22/2001 | CA2398979A1 Novel bee venom polypeptides and methods of use thereof |
11/21/2001 | EP1155130A2 Glucose dehydrogenase fusion proteins and their utilization in expression systems |
11/21/2001 | EP1155037A1 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists therof, and their therapeutic uses |
11/21/2001 | EP1154797A2 Multi-mutant diphtheria toxin vaccines |
11/21/2001 | CN1323225A Polymer conjugates of interferon beta-1a and their uses |
11/20/2001 | US6319704 Nucleotide sequences coding an enzymatic polypeptide; for use in the diagnosis and treatment of nervous system disorders |
11/20/2001 | US6319693 Cloning of chicken anemia virus DNA |
11/20/2001 | US6319686 Nucleotide sequences coding binding protein; for use as diagnostic, drug design and therapeutic tools |
11/20/2001 | CA2077691C Oxidation resistant thrombomodulin analogs |
11/20/2001 | CA2053864C Modified forms of reproductive hormones |
11/18/2001 | CA2722134A1 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof |
11/15/2001 | WO2001085980A2 Enzymatic assays for screening anti-cancer agents |
11/15/2001 | WO2001085944A2 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
11/15/2001 | WO2001085937A2 Regulator of g protein signalling (rgs8) |
11/15/2001 | WO2001085936A1 F-box containing protein |
11/15/2001 | WO2001085935A2 Endothelial differentiation gene 6-like g protein coupled receptor |
11/15/2001 | WO2001085934A1 New ras guanine-nucleotide-exchange factor 1 (nrg1) |
11/15/2001 | WO2001085921A2 Human serine-threonine kinase-4 |
11/15/2001 | WO2001085798A2 Human monoclonal antibodies to dendritic cells |
11/15/2001 | WO2001085797A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
11/15/2001 | WO2001085792A2 Mu-1, member of the cytokine receptor family |
11/15/2001 | WO2001085790A2 Mammalian cytokine receptor subunit proteins, related reagents and methods |
11/15/2001 | WO2001085785A2 Ph domain-interacting protein |
11/15/2001 | WO2001085779A2 Protein complexes and assays for screening anti-cancer agents |
11/15/2001 | WO2001085763A2 Chimeric peptide immunogens their preparation and use |
11/15/2001 | WO2001085762A2 Cancer diagnosis and assays for screening anti-cancer agents |
11/15/2001 | WO2001076627A8 Treatment of fungal infections with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies |
11/15/2001 | WO2001004344A3 Induction of a th1-like response in vitro |
11/15/2001 | WO2000078344A8 Prion protein peptides and uses thereof |
11/15/2001 | WO2000026370A9 Adenine nucleotide translocator (ant) fusion proteins and uses thereof |
11/15/2001 | CA2409515A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
11/15/2001 | CA2408828A1 Novel serine-threonine kinase-4 |
11/15/2001 | CA2408665A1 Novel regulator of g protein signalling |
11/15/2001 | CA2408664A1 F-box containing protein |
11/15/2001 | CA2408632A1 Ph domain-interacting protein |
11/15/2001 | CA2408594A1 Human monoclonal antibodies to dendritic cells |
11/15/2001 | CA2408571A1 Mammalian receptor proteins; related reagents and methods |
11/15/2001 | CA2408297A1 Cancer diagnosis and assays for screening anti-cancer agents |
11/15/2001 | CA2408213A1 Protein complexes and assays for screening anti-cancer agents |
11/15/2001 | CA2408002A1 Enzymatic assays for screening anti-cancer agents |
11/15/2001 | CA2407937A1 New ras guanine-nucleotide-exchange factor 1 (nrg1) |
11/15/2001 | CA2407886A1 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
11/14/2001 | EP1153036A1 Alpha-2-macroglobulin therapies and drug screening methods for alzheimer's disease |
11/14/2001 | EP1152734A1 Modified calycins |
11/14/2001 | EP1066380B1 Soluble t cell receptor |
11/14/2001 | CN1322246A Restin and methods of use thereof |
11/08/2001 | WO2001083811A1 Gamma secretase substrates and in vitro assays |
11/08/2001 | WO2001083772A1 Splice variant of camp phosphodiesterase type 7 (pde7a3) |
11/08/2001 | WO2001083771A2 Human phospholipase c delta 5 |
11/08/2001 | WO2001083768A2 Serine-threonine kinase |
11/08/2001 | WO2001083750A2 Dendritic cell co-stimulator molecules |
11/08/2001 | WO2001083745A1 New gtpase-activating protein 1 |
11/08/2001 | WO2001083744A2 Natrium-calcium exchanger protein |
11/08/2001 | WO2001083555A2 Pain signaling molecules |
11/08/2001 | WO2001083543A1 Human wingless-like gene |
11/08/2001 | WO2001083530A1 Porphyromonas gingivalis recombinant proteins and truncations |
11/08/2001 | WO2001083529A2 Immunoadhesin for the prevention of rhinovirus infection |
11/08/2001 | WO2001083525A2 Modified peptides, comprising an fc domain, as therapeutic agents |
11/08/2001 | WO2001083524A2 Rna metabolism proteins |
11/08/2001 | WO2001083522A2 Growth factor modified protein matrices for tissue engineering |
11/08/2001 | WO2001082975A2 Membrane-permeant peptide complexes for medical imaging |
11/08/2001 | WO2001082944A1 Methods and compositions for impairing multiplication of hiv-1 |
11/08/2001 | WO2001038348A3 G-protein coupled receptor htogh35 |
11/08/2001 | WO2001036489A3 Erythropoietin forms with improved properties |
11/08/2001 | US20010039008 Immunofluorescence |
11/08/2001 | CA2750984A1 Porphyromonas gingivalis recombinant proteins and truncations |
11/08/2001 | CA2409686A1 Serine-threonine kinase |
11/08/2001 | CA2408003A1 Gamma secretase substrates and in vitro assays |
11/08/2001 | CA2407959A1 Human wingless-like gene |
11/08/2001 | CA2407956A1 Modified peptides as therapeutic agents |
11/08/2001 | CA2407893A1 New gtpase-activating protein 1 |
11/08/2001 | CA2407887A1 Natrium-calcium exchanger protein |
11/08/2001 | CA2407604A1 Splice variant of camp phosphodiesterase type 7 (pde7a3) |
11/08/2001 | CA2407603A1 Porphyromonas gingivalis recombinant proteins and truncations |
11/08/2001 | CA2407601A1 Novel human phospholipase c delta 5 |
11/08/2001 | CA2407435A1 Rna metabolism proteins |
11/08/2001 | CA2407426A1 Immunoadhesin for the prevention of rhinovirus infection |
11/08/2001 | CA2407399A1 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
11/08/2001 | CA2407219A1 Pain signaling molecules |
11/08/2001 | CA2406746A1 Methods and compositions for impairing multiplication of hiv-1 |
11/07/2001 | EP1152060A1 5T4 tumour-associated antigen for use in tumour immunotherapy |
11/07/2001 | EP1151117A1 Intein-mediated protein ligation of expressed proteins |
11/07/2001 | EP1151101A1 Prostacyclin-stimulating factor-2 |
11/07/2001 | EP1151009A2 Antimicrobial/endotoxin neutralizing polypeptide |
11/07/2001 | EP1151001A2 Method for altering undesirable immune responses to polypeptides |
11/07/2001 | EP1151000A2 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor |
11/07/2001 | EP1150707A1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS |